| RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites V Dive, J Cotton, A Yiotakis, A Michaud, S Vassiliou, J Jiracek, G Vazeux, ... Proceedings of the National Academy of Sciences 96 (8), 4330-4335, 1999 | 217 | 1999 |
| Structure of astacin with a transition-state analogue inhibitor F Grams, V Dive, A Yiotakis, I Yiallouros, S Vassiliou, R Zwilling, W Bode, ... Nature structural biology 3 (8), 671-675, 1996 | 199 | 1996 |
| Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure− activity study S Vassiliou, A Mucha, P Cuniasse, D Georgiadis, K Lucet-Levannier, ... Journal of medicinal chemistry 42 (14), 2610-2620, 1999 | 141 | 1999 |
| RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no … C Junot, MF Gonzales, E Ezan, J Cotton, G Vazeux, A Michaud, M Azizi, ... Journal of pharmacology and experimental therapeutics 297 (2), 606-611, 2001 | 138 | 2001 |
| Design, synthesis, and evaluation of novel organophosphorus inhibitors of bacterial ureases S Vassiliou, A Grabowiecka, P Kosikowska, A Yiotakis, P Kafarski, ... Journal of Medicinal Chemistry 51 (18), 5736-5744, 2008 | 107 | 2008 |
| Protection of the hydroxyphosphinyl function of phosphinic dipeptides by adamantyl. Application to the solid-phase synthesis of phosphinic peptides A Yiotakis, S Vassiliou, J Jiráček, V Dive The Journal of organic chemistry 61 (19), 6601-6605, 1996 | 96 | 1996 |
| An effective one-pot synthesis of 3-benzylfurans and their potential utility as versatile precursors of 3, 4-dibenzyltetrahydrofuran lignans. Formal synthesis of (±)-burseran S Garçon, S Vassiliou, M Cavicchioli, B Hartmann, N Monteiro, G Balme The Journal of Organic Chemistry 66 (11), 4069-4073, 2001 | 71 | 2001 |
| The M18 aspartyl aminopeptidase of the human malaria parasite Plasmodium falciparum F Teuscher, J Lowther, TS Skinner-Adams, T Spielmann, MWA Dixon, ... Journal of Biological Chemistry 282 (42), 30817-30826, 2007 | 67 | 2007 |
| Computer-aided optimization of phosphinic inhibitors of bacterial ureases S Vassiliou, P Kosikowska, A Grabowiecka, A Yiotakis, P Kafarski, ... Journal of medicinal chemistry 53 (15), 5597-5606, 2010 | 65 | 2010 |
| Phosphinic peptides, the first potent inhibitors of astacin, behave as extremely slow-binding inhibitors I Yiallouros, S Vassiliou, A Yiotakis, R Zwilling, W Stöcker, V Dive Biochemical Journal 331 (2), 375-379, 1998 | 63 | 1998 |
| Structure-guided, single-point modifications in the phosphinic dipeptide structure yield highly potent and selective inhibitors of neutral aminopeptidases S Vassiliou, E Weglarz-Tomczak, Ł Berlicki, M Pawełczak, B Nocek, ... Journal of medicinal chemistry 57 (19), 8140-8151, 2014 | 59 | 2014 |
| A convenient method to synthesize phosphinic peptides containing an aspartyl or glutamyl aminophosphinic acid. Use of the phenyl group as the carboxyl synthon D Georgiadis, M Matziari, S Vassiliou, V Dive, A Yiotakis Tetrahedron 55 (51), 14635-14648, 1999 | 59 | 1999 |
| A synthetic method for diversification of the P1′ substituent in phosphinic dipeptides as a tool for exploration of the specificity of the S1′ binding pockets of leucine … S Vassiliou, M Xeilari, A Yiotakis, J Grembecka, M Pawełczak, P Kafarski, ... Bioorganic & medicinal chemistry 15 (9), 3187-3200, 2007 | 44 | 2007 |
| Phosphinic peptide inhibitors as tools in the study of the function of zinc metallopeptidases. V Dive, K Lucet-Levannier, D Georgiadis, J Cotton, S Vassiliou, ... Biochemical Society Transactions 28 (4), 455-460, 2000 | 39 | 2000 |
| Cyclic peptides with a phosphinic bond as potent inhibitors of a zinc bacterial collagenase A Yiotakis, A Lecoq, S Vassiliou, I Raynal, P Cuniasse, V Dive Journal of medicinal chemistry 37 (17), 2713-2720, 1994 | 38 | 1994 |
| Discovery of potent and selective inhibitors of human aminopeptidases ERAP1 and ERAP2 by screening libraries of phosphorus-containing amino acid and dipeptide analogues E Węglarz-Tomczak, S Vassiliou, A Mucha Bioorganic & Medicinal Chemistry Letters 26 (16), 4122-4126, 2016 | 31 | 2016 |
| Integrated Transition Metal Catalysed Reactions: Synthesis of Polysubstituted 4‐(Phenoxymethyl)‐3‐pyrrolines and Their Isomers by One‐Pot Coupling of Propargylamines, Vinyl … B Clique, S Vassiliou, N Monteiro, G Balme European Journal of Organic Chemistry 2002 (9), 1493-1499, 2002 | 29 | 2002 |
| Covalent inhibition of bacterial urease by bifunctional catechol-based phosphonates and phosphinates A Pagoni, A Grabowiecka, W Tabor, A Mucha, S Vassiliou, Ł Berlicki Journal of Medicinal Chemistry 64 (1), 404-416, 2020 | 22 | 2020 |
| Novel anti-Alzheimer phenol-lipoyl hybrids: Synthesis, physico-chemical characterization, and biological evaluation A Pagoni, L Marinelli, A Di Stefano, M Ciulla, H Turkez, A Mardinoglu, ... European Journal of Medicinal Chemistry 186, 111880, 2020 | 20 | 2020 |
| Three component Kabachnik-Fields condensation leading to substituted aminomethane-P-hydroxymethylphosphonic acids as a tool for screening of bacterial urease inhibitors S Vassiliou, A Grabowiecka, P Kosikowska, Ł Berlicki Arkivoc 4, 33-43, 2012 | 20 | 2012 |
